Global Virology V: 21st Century Vaccines and Viruses

Erscheinungsjahr 2025
ISBN: 978-3-031-77910-7
Verlag: Springer

Buch, Englisch, 857 Seiten, Format (B × H): 160 mm x 241 mm, Gewicht: 1453 g

The purpose of this fifth volume in the Global Virology series is to describe and propose vaccines, focusing primarily on viral vaccines. In addition to human vaccines, animal viral vaccines are  included since animals are used in vaccine research, and the spread of diseases to, from, and among animals, birds, and humans permeates the ecosystem. 

Due to climatic, geographical, and social factors, there is increased global spread of viruses and other infectious agents. Contributory factors include global warming, spread of vectors, increased human travel, encroachment into animal and avian environments, war, pestilence, malnutrition, and environmental, economic, and social collapse.  

GVV will address vaccines for many of the viruses addressed in previous series volumes, as well as for viruses not previously covered, and novel and future vaccine technologies.  Advances in vaccine effectiveness and molecular engineering approaches are included, such as gene therapy, and CRISPR technologies.

Zielgruppe

Research

Autoren/Hrsg.

Shapshak, Paul

Balaji, Seetharaman

Kangueane, Pandjassarame

Kuhn, Jens H.

Somboonwit, Charurut

Sinnott, John T.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Immunologie
• Naturwissenschaften Biowissenschaften Mikrobiologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie

Inhaltsverzeichnis

1-15. Individual virus vaccines  (Nipah, Hendra/Nipah/Henipaviridae peptides, Circovirus, Hantavirus, Prion, Influenza, Zika, Venezuelan EEV, HIV, etc.).- 16. Cut-across vaccines.- 17. Strategies in vaccine development and testing.- 18. Prior and anticipated barriers to vaccines.- 19. Sociological and psychiatric barriers to vaccines.- 20. International issues and barriers in vaccine development and promulgation.- 21. Clinical applications of vaccine development, promulgation, and testing.- 22. Applications of CRISPR.- 23. Applications of siRNA.- 24. Nano-molecular vaccine adjuvant technology.-  25. Vaccine development in education.- 26. The intersection of animal, avian, and insect worlds.- 27. Honeybee discrimination.- 28. Jumping genes in maize.- 29. Exclusion of gene expression.

Über Autor(innen)

Paul Shapshak, PhD, is an Adjunct Professor in the Department of Internal Medicine, Division of Infectious Diseases and International Health, University of South Florida, Morsani College of Medicine, in Tampa, Florida, USA. His background is in molecular biology, virology, neuro-immunology, and drug abuse research.

Setharam Balaji, PhD, is an Associate Professor (Sr. Scale) in the Department of Biotechnology, Manipal Institute of Technology, Manipal Academy of Higher Education (MAHE), Manipal, Karnataka-576104, India.  His background is in biochemistry, bioinformatics, and drug design. 

Pandjassaramme Kangueane, PhD, is the Director of Biomedical Informatics Private Limited, India and is the Chief Editor of Bioinformation, an open access journal in Biological Knowledge Discovery, India. His research interest is in HLA based short peptide vaccine design and in protein-protein interactions.

Jens Kuhn, MD, PhD, is lead virologist at the Integrated Research Facility, part of the National Interagency Biodefense Campus at the NIH/NIAID. He specializes in highly virulent viral pathogens. 

Charurut Somboonwit, MD, is a Professor in the Department of Internal Medicine, Division of Infectious Diseases and International Health, University of South Florida, Morsani College of Medicine, in Tampa, Florida, USA. . Her expertise is in communicable diseases and HIV medicine.

John T. Sinnott, MD, is in the Department of Internal Medicine at the University of South Florida Morsani College of Medicine, and the Director of the Florida Infectious Disease Institute. His expertise is in infectious diseases.